Annals of Oncology

In this issue:

In this issue
Ann Oncol 4: 705.
[PDF] [Request Permissions]

Contents of the next issue:

Contents of the next issue
Ann Oncol 4: 705.
[PDF] [Request Permissions]

News:

‘Gene of the Year’ p53: When will it show clinical promise?
Ann Oncol 4: 706-707.
[PDF] [Request Permissions]

U.K. prevention trial gets ‘go-ahead’ and expands to other countries
Ann Oncol 4: 707-708.
[PDF] [Request Permissions]

Socioeconomic status more influential than smoking?
Ann Oncol 4: 708.
[PDF] [Request Permissions]

ESMO Congress 1994: More education, new rules
Ann Oncol 4: 708.
[PDF] [Request Permissions]

Luc Montagnier can wait
Ann Oncol 4: 708.
[PDF] [Request Permissions]

GM prize to Fisher and Banadonna elicits indignation
Ann Oncol 4: 709.
[PDF] [Request Permissions]

Awards lectures at ECCO-7, Jerusalem
Ann Oncol 4: 709.
[PDF] [Request Permissions]

Awards, appointments
Ann Oncol 4: 709.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 4: 710-711.
[PDF] [Request Permissions]

Book reviews:

Hans Neuenschwander

Book review
Ann Oncol 4: 711.
[PDF] [Request Permissions]

G. Stoter

Book Review
Ann Oncol 4: 713.
[PDF] [Request Permissions]

M. D'Incalci

Book review
Ann Oncol 4: 715.
[PDF] [Request Permissions]

Martin F. Fey

Book review
Ann Oncol 4: 721.
[PDF] [Request Permissions]

Editorials:

R. D. Rubens

Towards improved endocrine therapy for advanced breast cancer
Ann Oncol 4: 712-713.
[PDF] [Request Permissions]

Marzio E.E Sabbioni, M.D.

Is a bio-psycho-social approach in cancer research feasible?
Ann Oncol 4: 714-715.
[PDF] [Request Permissions]

Special articles:

R. Cellerino, F. Graziano, A. Piga, and V. Ghetti

The teaching of clinical oncology in Italian medical schools. A survey among teachers and students
Ann Oncol 4: 717-721.
[Abstract] [PDF] [Request Permissions]

Review:

E. DelaFlor-Weiss, B. Uziely, and F. M. Muggia

Protracted drug infusions in cancer treatment: An appraisal of 5-fluorouracil, doxorubicin, and platinums
Ann Oncol 4: 723-733.
[Abstract] [PDF] [Request Permissions]

Original articles:

M. Castiglione-Gertsch, S. Pampallona, M. Varini, F. Cavalli, K. Brunner, H. J. Senn, A. Goldhirsch, and U. Metzger

Primary endocrine therapy for advanced breast cancer: To start with tamoxifen or with medroxyprogesterone acetate?
Ann Oncol 4: 735-740.
[Abstract] [PDF] [Request Permissions]

P. G. Gill, V. Gebski, R. Snyder, I. Burns, J. Levi, M. Byrne, and A. Coates

Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer
Ann Oncol 4: 741-744.
[Abstract] [PDF] [Request Permissions]

D. H. Bovbjerg and H. Valdimarsdottir

Familial cancer, emotional distress, and low natural cytotoxic activity in healthy women
Ann Oncol 4: 745-752.
[Abstract] [PDF] [Request Permissions]

A. Cervantes, A. Villar-Grimalt, A. Abad, A. Antón-Torres, J. Belón, J. Dorta, A. Tres, C. Camps, E. Fonseca, B. Massutí, E. Aranda, E. Blanco, M. García de Paredes, J. J. Sánchez Hernández, J. García-Conde, E. Díaz-Rubio, and for the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD)

5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy
Ann Oncol 4: 753-757.
[Abstract] [PDF] [Request Permissions]

A. M. Gianni, S. Siena, M. Bregni, M. Di Nicola, F. Peccatori, M. Magni, F. Ravagnani, I. Sklenar, and G. Bonadonna

Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m²) cyclophosphamide cancer therapy
Ann Oncol 4: 759-766.
[Abstract] [PDF] [Request Permissions]

P.J. Bierman, R.G. Bagin, S. Jagannath, J.M. Vose, G. Spitzer, A. Kessinger, K.A. Dicke, and J.O. Armitage

High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: Long term follow-up in 128 patients
Ann Oncol 4: 767-773.
[Abstract] [PDF] [Request Permissions]

F. Morali, M. Cattabeni, E. Tagliabue, M. Campiglio, S. Menard, M. Marzola, V. Lucchini, N. Colombo, C. Mangioni, L. Redaelli, and M. D'Incalci

Overexpression of p185 is not related to erbB2 amplification in ovarian cancer
Ann Oncol 4: 775-779.
[Abstract] [PDF] [Request Permissions]

Clinical case:

R. A. Joss and J.-O. Gebbers

Mediastinal mass with fever and night sweats in a young farmer - potential pitfalls in the diagnostic work-up and treatment
Ann Oncol 4: 781-784.
[PDF] [Request Permissions]

Short reports:

J. B. Vermorken, J. Verweij, P. H. M. de Mulder, F. Cognetti, M. Clavel, S. Rodenhuis, A. Kirkpatrick, and G. B. Snow

Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: A phase II study of the EORTC Head and Neck Cancer Cooperative Group
Ann Oncol 4: 785-788.
[Abstract] [PDF] [Request Permissions]

A. van der Gaast, S. C. Henzen-Logmans, A. S. Th Planting, G. Stoter, and J. Verweij

Phase II study of oral administration of etoposide for patients with well- and moderately-differentiated adenocarcinomas of unknown primary site
Ann Oncol 4: 789-790.
[Abstract] [PDF] [Request Permissions]

E. van der Wall, D. J. Richel, Y. H. Kusumanto, E. J. T. Rutgers, J. H. Schornagel, C. C. E. Schaake-Koning, J. L. Peterse, and S. Rodenhuis

Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer
Ann Oncol 4: 791-792.
[Abstract] [PDF] [Request Permissions]

Letters:

J. Kattan, S. Culine, C. Théodore, and J.-P. Droz

Letters to the editor: Second-line M-VAC therapy in patients previously treated with the M-VAC regimen for metastatic urothelial cancer
Ann Oncol 4: 793-794.
[PDF] [Request Permissions]

A. J. Lacave

Euthanasia: Less confusion from the professional point of view
Ann Oncol 4: 794.
[PDF] [Request Permissions]

F. Roila, E. Ballatori, and A. Del Favero

Antiemetic therapy: The state of the art
Ann Oncol 4: 795.
[PDF] [Request Permissions]

S. B. Kaye

The above letter was referred to the author, who responds as follows:
Ann Oncol 4: 795.
[PDF] [Request Permissions]

Advertisements in this issue:

Kluwer Academic Publishers
Ann Oncol 4: 796.
[PDF] [Request Permissions]

Classified advertisements from ESMO members and meeting anncouncements
Ann Oncol 4: 797.
[PDF] [Request Permissions]

ESMO applications for membership
Ann Oncol 4: 798.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.